메뉴 건너뛰기




Volumn 27, Issue 18, 2009, Pages 2410-2413

Booster vaccination of toddlers with reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

Author keywords

Acellular pertussis vaccine; Booster; Vaccination

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE;

EID: 62949195584     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.065     Document Type: Article
Times cited : (2)

References (17)
  • 1
    • 0036677181 scopus 로고    scopus 로고
    • Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids
    • Jackson L.A., Carste B.A., Malais D., and Froeschle J. Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr Infect Dis J 21 8 (2002) 781-786
    • (2002) Pediatr Infect Dis J , vol.21 , Issue.8 , pp. 781-786
    • Jackson, L.A.1    Carste, B.A.2    Malais, D.3    Froeschle, J.4
  • 2
    • 0035258590 scopus 로고    scopus 로고
    • Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines
    • Tozzi A.E., Anemona A., Stefanelli P., Salmaso S., Ciofi degli Atti M.L., Mastrantonio P., et al. Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 107 2 (2001) e25
    • (2001) Pediatrics , vol.107 , Issue.2
    • Tozzi, A.E.1    Anemona, A.2    Stefanelli, P.3    Salmaso, S.4    Ciofi degli Atti, M.L.5    Mastrantonio, P.6
  • 3
    • 0034785553 scopus 로고    scopus 로고
    • Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group
    • Liese J.G., Stojanov S., Zink T.H., Froeschle J., Klepadlo R., Kronwitter A., et al. Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 20 10 (2001) 981-988
    • (2001) Pediatr Infect Dis J , vol.20 , Issue.10 , pp. 981-988
    • Liese, J.G.1    Stojanov, S.2    Zink, T.H.3    Froeschle, J.4    Klepadlo, R.5    Kronwitter, A.6
  • 5
    • 0042427486 scopus 로고    scopus 로고
    • Local reactions after the fourth dose of acellular pertussis vaccine in South Australia
    • Gold M.S., Noonan S., Osbourn M., Precepa S., and Kempe A.E. Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 179 4 (2003) 191-194
    • (2003) Med J Aust , vol.179 , Issue.4 , pp. 191-194
    • Gold, M.S.1    Noonan, S.2    Osbourn, M.3    Precepa, S.4    Kempe, A.E.5
  • 7
    • 62949123448 scopus 로고    scopus 로고
    • The Australian immunisation handbook. 8th ed. Canberra: NHMRC;September 2003:210.
    • The Australian immunisation handbook. 8th ed. Canberra: NHMRC;September 2003:210.
  • 8
    • 62949224888 scopus 로고    scopus 로고
    • Available at, Accessed on 26.02.08
    • Pediatric guidelines. NKF K/DOQI guidelines 2000. Available at http://www.kidney.org/professionals/KDOQI/guidelines_updates/nut_appx1p. html. Accessed on 26.02.08.
    • (2000) Pediatric guidelines. NKF K/DOQI guidelines
  • 9
    • 35648942210 scopus 로고    scopus 로고
    • Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine
    • Saenger R., Behre U., Krause K.H., Loch H.P., Soemantri P., Herrmann D., et al. Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine. Eur J Pediatr 166 12 (2007) 1229-1236
    • (2007) Eur J Pediatr , vol.166 , Issue.12 , pp. 1229-1236
    • Saenger, R.1    Behre, U.2    Krause, K.H.3    Loch, H.P.4    Soemantri, P.5    Herrmann, D.6
  • 10
    • 4944225305 scopus 로고    scopus 로고
    • Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
    • Collins C.L., Salt P., McCarthy N., Chantler T., Lane L., Hemme F., et al. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22 31-32 (2004) 4262-4269
    • (2004) Vaccine , vol.22 , Issue.31-32 , pp. 4262-4269
    • Collins, C.L.1    Salt, P.2    McCarthy, N.3    Chantler, T.4    Lane, L.5    Hemme, F.6
  • 11
    • 48249091958 scopus 로고    scopus 로고
    • Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: Standard pediatric versus a reduced-antigen content formulation
    • Meyer C.U., Habermehl P., Knuf M., Hoet B., Wolter J., and Zepp F. Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: Standard pediatric versus a reduced-antigen content formulation. Hum vaccin 4 3 (2008) 30-36
    • (2008) Hum vaccin , vol.4 , Issue.3 , pp. 30-36
    • Meyer, C.U.1    Habermehl, P.2    Knuf, M.3    Hoet, B.4    Wolter, J.5    Zepp, F.6
  • 12
    • 7744238483 scopus 로고    scopus 로고
    • Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model
    • Cheuvart B., Burgess M., Zepp F., Mertsola J., Wolter J., and Schuerman L. Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model. Vaccine 23 3 (2004) 336-342
    • (2004) Vaccine , vol.23 , Issue.3 , pp. 336-342
    • Cheuvart, B.1    Burgess, M.2    Zepp, F.3    Mertsola, J.4    Wolter, J.5    Schuerman, L.6
  • 13
    • 33745108956 scopus 로고    scopus 로고
    • Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life
    • Knuf M., Habermehl P., Faber J., Bock H.L., Sanger R., Bogaerts H., et al. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Vaccine 24 27-28 (2006) 5627-5636
    • (2006) Vaccine , vol.24 , Issue.27-28 , pp. 5627-5636
    • Knuf, M.1    Habermehl, P.2    Faber, J.3    Bock, H.L.4    Sanger, R.5    Bogaerts, H.6
  • 14
    • 20944450420 scopus 로고    scopus 로고
    • Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age
    • Vergara R., Tregnaghi M., Ussher J., Navarro S., Ruttimann R., Potin M., et al. Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age. Eur J Pediatr 164 6 (2005) 377-382
    • (2005) Eur J Pediatr , vol.164 , Issue.6 , pp. 377-382
    • Vergara, R.1    Tregnaghi, M.2    Ussher, J.3    Navarro, S.4    Ruttimann, R.5    Potin, M.6
  • 16
    • 0035512245 scopus 로고    scopus 로고
    • Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience
    • Salmaso S., Mastrantonio P., Tozzi A.E., Stefanelli P., Anemona A., Ciofi degli Atti M.L., et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 108 5 (2001) e81
    • (2001) Pediatrics , vol.108 , Issue.5
    • Salmaso, S.1    Mastrantonio, P.2    Tozzi, A.E.3    Stefanelli, P.4    Anemona, A.5    Ciofi degli Atti, M.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.